There is a number of reports on the effects of eicosapentaenoic acid (EPA) on tumor growth. Since it is well known that EPA is very unstable, it seems likely that the by-products (EPA derivatives, EPAD) formed from EPA ethylester (an original product) during the accelerated stability test might have lower antitumor activity compared with EPA ethylester. However, the O
2- production in Lewis lung carcinoma (LLC) cells by EPA ethylester was similar to that in EPAD-treated LLC cells. We obtained two EPA derivatives (E-1 and E-2) as well as EPA ethylester (non-reactive substance), EPA (free form) from EPA ethylester under storage conditions of 60±5% relative humidity at 37°C for 30 days. E-1 and E-2 were identified as EPA ethylester dimer and EPA hydroxyethylester, respectively, by the analysis of the
1H-NMR and
13C-NMR spectra and MS spectrum. The inhibitory effect of E-1 and E-2 on the DNA synthesis in Lewis lung tumor cells was greater than that of EPA ethylester. EPA ethylester, E-1 and E-2 increased the O
2- production by LLC cells at a concentration of 0.033 to 3.3 g/mL, and the effects of E-1 was stronger than that of EPA ethylester. The inhibitory effects of E-1 and E-2 on Matrigel-induced capillary-like network formation were stronger than the effect of EPA ethylester. These findings suggest that EPA ethylester dimer (E-1) and EPA hydroxyethylester (E-2) formed from EPA ethylester (an original product) by the accelerated stability test may be a candidate compound for antitumor agents as well as the antitumor action of EPA ethylester.
View full abstract